Modification-dependent and -independent biomolecular interactions (BIs), including protein-protein, protein-DNA/RNA and protein-lipid, play crucial roles in all cellular processes. Dysregulation of BIs or malfunction of the associated enzymes results in various diseases, thus they are attractive targets for therapies. High-throughput screening (HTS) can greatly facilitate the discovery of drugs for these targets. Here we describe a HTS drug discovery method, called compartmentalization of enhanced biomolecular interactions in test tubes (CEBIT). CEBIT uses selective recruitment of biomolecules into phase separated compartments harboring their cognate binding partners as readouts.
Introduction
Complex networks of modification-dependent and -independent biomolecular interactions (BIs) lay the foundation of diverse cellular processes including DNA replication, transcription, protein translation, and signal transduction. Dysregulation of BIs causes many diseases, such as neurodegenerative diseases, infection and cancers 1, 2 .
Hence, aberrant BIs and the associated modifying enzymes, if any, are attractive targets for therapeutic drug discovery [3] [4] [5] .
High-throughput screening (HTS) provides a powerful strategy for the discovery of drugs that modulate various BIs 6 . Many HTS technologies are widely used, such as surface plasmon resonance (SPR), fluorescence polarization (FP) and fluorescence resonance energy transfer (FRET). These methods all have major limitations. Many factors can interfere with the outcomes of SPR, such as ionic strength, DMSO content, charges of immobilized proteins, and nonspecific binding to the biosensor [7] [8] [9] [10] . FP requires not only a big difference in molecular mass between the fluorescent probe and the target protein, but also high affinity probe to achieve large signal window 9, 11 . These drawbacks largely limit its application. FRET, a third commonly used HTS method, has a narrow signal window and high background due to the limited energy transfer distance (<10 nm) 9, 11, 12 . It is vital to develop more robust and easily implementable HTS technologies for efficient drug discovery.
Cells use numerous membrane-enclosed and membraneless organelles to compartmentalize biochemical reactions. Membraneless organelles, such as P granules 13 , nucleoli 14 , stress granules 15 , and post synaptic densities 16 , are collectively referred to as biomolecular condensates. These condensates are assembled via liquid-liquid phase separation (LLPS) driven by multivalent interactions 17, 18 . Generally, the constituents of various condensates are divided into two groups: one group is composed of scaffolds, which are essential for the assembly of these condensates and the other group is composed of clients, which are dispensable for the formation of the condensates but can partition into these condensates via directly or indirectly binding to the scaffolds 19 . Inspired by the scaffold-client model, we explored the possibility of using a similar architecture to implement a system for assaying modification-dependent and -independent BIs, which can be used for efficient discovery of drugs targeting these BIs and associated enzymes.
Our system consists of two parts: (1) the scaffold, which drives the formation of phase separated compartments; and (2) the BI of interest, of which one partner is fused with the scaffold to generate a composite scaffold and hence automatically enriched in the compartments and the other partner (defined as client) is recruited to the compartments via specific interaction. For visualization, the composite scaffold and the client are labeled with different fluorescent probes such as GFP and mCherry. Thus, the BI of interest is assessed by the enrichment of mCherry fused client within the GFP labeled phase separated compartments. This design can also be used to measure the activities of enzymes modifying biomolecules. This strategy is called compartmentalization of enhanced biomolecular interactions in test tubes (CEBIT). We also developed and evaluated a similar method for studying protein-protein interactions (PPIs) in cells (see the accompanying manuscript). We extensively validated CEBIT using some representative PPI pairs. Subsequently, we tailored CEBIT to probe molecular modifications and the associated enzymes. CEBIT is very amenable for HTS. Using the MDM2/p53 interaction and the SUV39H1-mediated H3K9 methylation reaction as two test cases, we successfully identified inhibitors of the MDM2/p53 interaction and of SUV39H1 from a commercial compound library. CEBIT is a simple and versatile method, which will have many applications in basic and translational research.
Results

Establishing robust multivalent scaffolds
First, we sought to establish some multivalent scaffolds that can robustly drive the formation of compartments via LLPS. Numerous studies have demonstrated that interactions between linear and/or dendrimeric (branched) multivalent modular proteins can result in LLPS 17, [19] [20] [21] [22] . The Saccharomyces cerevisiae protein SmF (referred to as SmF hereafter) is known to form a stable tetradecameric (referred to as 14-meric for simplicity hereafter) complex upon expression alone in bacteria 23 . We tested whether it was possible to reliably achieve dendrimeric multivalence of various domains/motifs when they were fused to SmF. We created two fusion proteins, one with green fluorescent protein (GFP) fused to the C-terminus of SmF (SmF-GFP) and the other with the second Src homology 3 (SH3) domain of human NCK1 fused to the C-terminus of SmF-GFP (SmF-GFP-SH3). Size-exclusion chromatography coupled with multi-angle light scattering (SEC-MALS) analysis indicated that SmF-GFP also formed a 14-meric complex in solution, and further fusion of a SH3 domain to SmF-GFP did not alter the 14-meric status ( Fig. 1a ). Therefore, we concluded that SmF is a robust 14-meric protein for multimerizing protein domains/motifs. Similarly, we investigated the Bacillus subtilis protein Hfq (BsHfq), which is known to form a stable hexameric complex 24 . We confirmed that BsHfq can reliably achieve dendrimeric multivalence of fused domains/motifs ( Fig. S1 ).
Multimerized PPIs undergo LLPS
Next, we investigated whether multimerized PPIs, created by fusion to SmF, could mediate LLPS. We selected three model PPI pairs: (1) the second SH3 domain of human NCK1 and the proline-rich motif (PRM) of DLGAP2 17 ; (2) the third PDZ domain of human PSD95 and its ligand, KKETPV (abbreviated to PV) 25 ; and (3) SUMO3 and the SUMO3 interacting motif (SIM) 19 . In each PPI pair, one partner was fused to SmF-GFP and the other was fused to SmF-mCherry ( Fig. S2a ). The resulting proteins are abbreviated as (g/mDOMAIN/MOTIF NAME)14 for simplicity, in which g/m stands for GFP/mCherry and the subscript 14 represents the 14-meric status of the protein complexes. We carried out cross-mixing reactions between (gSH3)14, (gPDZ)14, or (gSUMO3)14 and (mPRM)14, (mPV)14, or (mSIM)14. All three cognate multivalent PPI pairs, but not the non-interacting PPI pairs, gave rise to marked LLPS ( Fig. 1b) . We next carried out phase-separation assays of (gSH3)14 and (mPRM)14 at 1:1 molar ratio over a large module concentration range, 100 nM to 10 M. Numerous droplets formed at module concentrations as low as 100 nM (Fig. 1c ). We further fused all binary combinations of the three modules, SH3, PDZ, and SUMO3, to the C-terminus of SmF-GFP to yield six composite scaffolds, in which two different interacting domains are present in two different orders ( Fig. S2b ).
Cross-mixing the six proteins with (mPRM)14, (mPV)14, or (mSIM)14 showed that LLPS occurs as long as and only if a cognate multivalent PPI pair is present ( Fig. 1d ). These results suggest that the presence of a non-cognate binding module does not appreciably affect the ability of multivalent PPI to drive LLPS. Collectively, these data further revealed the robustness of SmF as a multivalent scaffold to multimerize PPIs for inducing LLPS.
Recruitment of clients into phase-separated compartments via specific PPIs
As revealed by Banani et al., clients are recruited into scaffold-induced condensates by binding to free sites of scaffolds 19 . We wondered whether PPIs of interest could be studied similarly as clients. To test this, we used (gSH3-PDZ)14 (abbreviated for SmF-GFP-SH3-PDZ, Fig. S2c ) and (gPRM)14 to drive LLPS, presumably via the multivalent SH3/PRM interaction, and we simultaneously used mCherry-fused PDZ ligand, KKETPV (abbreviated to mPV, Fig. S2c ), as a client to assess the interaction between PDZ and KKETPV ( Fig. 2a ). (gSH3-PDZ)14 and (gPRM)14 formed green compartments ( Fig. 2b , lower panels). mPV was recruited into these droplets, as shown by the enriched mCherry signal ( Fig. 2b , KKETAV = 0 M). To test whether the recruitment is reversible, we used a peptide, KKETAV, which has a slightly higher affinity for PDZ than KKETPV 25 , to compete with mPV. The enrichment of mPV was gradually reduced by increasing concentrations of the competing peptide ( Fig. 2b, red) , which was confirmed by quantification of mCherry signal in the green droplets ( Fig. 2c ). These results indicated that mPV was recruited into droplets via binding to PDZ. FKBP/FRB is a well-characterized high-affinity interaction that is mediated by rapamycin 26 . We wondered whether our system can assay similar interactions. We generated a composite scaffold (gSH3-FKBP)14 (abbreviated for SmF-GFP-SH3-FKBP) and the corresponding client mFRB (abbreviated for mCherry-FRB) ( Fig. 2d and S2c).
(gSH3-FKBP)14 readily underwent phase separation with (gPRM)14. Additionally, in the presence of increasing concentrations of rapamycin, but not the negative control ampicillin, recruitment of mFRB into the green droplets increased in parallel, as indicated by the enhanced mCherry signal ( Fig. 2e-f ).
Subsequently we focused on two well-known cancer-related targets, MDM2 and XIAP.
MDM2, an endogenous inhibitor of the tumor suppressor protein p53, binds to the N-terminal transactivation domain of p53 and mediates its degradation 27, 28 . XIAP is a suppressor of the proapoptotic protein caspase-9. The suppression is alleviated by the binding of Smac to the Bir3 domain of XIAP 29 . Importantly, potent inhibitors of MDM2 and XIAP have been developed 5, 30, 31 . We chose MDM2/p53 and Smac/XIAP to assess the feasibility of using CEBIT for drug discovery. The MDM2-binding region of p53 was fused with (gSH3)14 to generate the composite scaffold (gSH3-p53)14 and MDM2 was labeled with mCherry (abbreviated to mMDM2) as the client ( Fig. 2g and S2c). As the concentration of mMDM2 increased, its enrichment in the green droplets formed by (gSH3-p53)14 and (gPRM)14 was significantly increased ( Fig. 2h -i). This enrichment was significantly reduced by two potent MDM2 inhibitors, MI773 and RG7388 ( Fig. 2h-i) .
Similarly, the XIAP-binding region of Smac was fused to the N-terminus of SmF-SH3 to generate (Smac-SH3)14 (abbreviated for Smac-SmF-SH3) as a composite scaffold and the Bir3 domain of XIAP was tagged by SNAP as the client (Fig. S2d ). Phase separation of (Smac-SH3)14 and (gPRM)14 formed green droplets, into which SNAP-Surface 546-labeled SNAP-XIAP was recruited ( Fig. S3 ). This recruitment was blocked by the XIAP inhibitor GDC-0152 ( Fig. S3 ). These data demonstrate that CEBIT is competent for studying various PPIs by conjugating one member of the target PPI to a phase-separated scaffold and the other to a fluorescent label as the client.
A high-throughput screening assay targeting the MDM2/p53 interaction Next, we asked whether CEBIT can be used for drug discovery via HTS. We tested the effects of compounds in a commercial library on the MDM2/p53 interaction with above established assay. The library contains 2148 compounds, including five known inhibitors of MDM2/p53, Nutlin-3, Nutlin-3a, Nutlin-3b, YH239-EE and MI773. The activity of each compound was determined by assessing the enrichment of mMDM2 in the p53-containing droplets. Most compounds did not inhibit the recruitment of mMDM2. However, all five known MDM2 inhibitors ( Fig. 3a , the 5 red dots) significantly reduced the mCherry signal and were the most effective inhibitors among all the compounds tested. Treatment with the five known inhibitors resulted in mCherry signals well over four standard deviations below the mean, which indicates that the screening process is effective. In addition, we found another compound, VER (abbreviated for VER155008, Fig. 3a , the green dot), which strongly attenuated mMDM2 enrichment, suggesting that it is a potential MDM2/p53 inhibitor. Fluorescence images confirmed that these inhibitors decreased the enrichment of mMDM2 in the phase-separated droplets (Fig. 3b ).
The Z factor is a critical quality control parameter for HTS assays and it was 0.52 for our screen (Fig. 3a ), which suggests that our assay is excellent for HTS 32 Detailed dose-response analysis confirmed the inhibitory activities of these screening hits ( Fig. 3c and S5 ). Next, a competitive fluorescence polarization (FP) assay using a high affinity fluorescent probe P4 33 was performed to confirm the inhibitory effect of the newly identified compound VER on the MDM2/p53 interaction. Two known MDM2 inhibitors, MI773 and Nutlin-3b, were used as controls. The control inhibitors caused an apparent decrease in polarization as their concentration increased, but VER failed to do so ( Fig. 3d ). This result suggested that CEBIT is more sensitive than FP. Collectively, these data revealed that CEBIT has the potential for drug discovery via HTS.
Tailoring CEBIT to probe reader-based molecular modifications
Regulated chemical modifications (including methylation, acetylation, phosphorylation) of various biomacromolecules, such as proteins, RNAs, and DNAs, are extremely important for all aspects of biology. Aberrant modifications, and the associated enzymes are attractive therapeutic targets. However, efficient HTS assays that are generally applicable to the discovery of drugs modulating these enzymes are still lacking.
These modifications can often be recognized by specific effector proteins via their reader domains. We postulated that CEBIT can be adopted for examining these modifications and the activities of the associated modifying enzymes. Our strategy is to confine specific reader domains in phase-separated compartments via fusion to the scaffold and use the modification-dependent recruitment of cognate substrates as the readout for the enzymatic activities of interest.
Here we used methylation of biomacromolecules (proteins, RNAs, and DNAs) as examples to test our idea. Protein lysine methylation plays important roles in various biological pathways. For example, methylation of the histone H3 lysine 9 (H3K9me) is a hallmark of heterochromatin in cells. We wonder whether this modification can be detected with CEBIT. To this end, we fused the human HP1β chromo domain (CD), a well-known reader domain of H3K9me [34] [35] [36] , to (gSH3)14, resulting in a composite scaffold (gSH3-CD)14 ( Fig. 4a and S2e). We also fused H3K9 peptides (carrying different levels of lysine methylation) with the PDZ ligand, KKETPV, to create H3K9-KKETPV (abbreviated to H3K9-PV). Our strategy was to create droplets via LLPS of (gSH3-CD)14 in the presence of (gPRM)14 and then to determine the enrichment of H3K9-PV within the droplets by the further recruitment of mCherry labeled PDZ ( Fig. 4a ). We first used mono methylated H3K9-PV peptide (H3K9(me1)-PV) to test our design. As indicated, (gSH3-CD)14 and (gPRM)14 formed green droplets; however, a very weak mCherry signal was observed in the presence of mPDZ ( Fig. 4b ). To enhance the signal, mPDZ was multimerized by fusing with the hexameric protein BsHfq, resulting in (mPDZ)6 ( Fig. S1 and S2e). Compared with mPDZ, (mPDZ)6 significantly enhanced the mCherry signal within the green droplets ( Fig. 4b ), which was confirmed by quantification ( Fig. 4c ). Hence, (mPDZ)6 was used for subsequent H3K9 methylation related studies.
Next, we used mixtures of H3K9(me0)-PV and H3K9(me1)-PV with increasing ratios of the latter to mimic the methylation reaction process. As the proportion of H3K9(me1)-PV increased, the mCherry signal increased in parallel ( Fig. 4d-e ). We next analyzed the effect of the methylation status of the H3K9-PV peptide (from me0 to me3) and found that higher levels of methylation resulted in stronger mCherry signals ( Fig. 4f-g) , which was consistent with the binding preference of HP1β chromo domain 37, 38 .
We subsequently studied the methylation of DNA and RNA with CEBIT. The appreciably enriched within these droplets, and the latter was more strongly enriched than the former (Fig. S6b ). This observation was further confirmed by quantification of ROX intensity in the droplets (Fig. S6b ). Additionally, when mixtures of DNA(0me) and DNA(2me) with various ratios but at a constant total concentration were used, the enrichment of ROX signal in MBD-containing droplets was proportional to the ratio of DNA(2me) (Fig. S6c ). For RNA, identical experiments were performed and similar results were achieved ( Fig. S6d-e ). Collectively, these results showed that CEBIT can effectively probe the methylation of biomacromolecules.
CEBIT-based HTS for SUV39H1 inhibitors
SUV39H1 is a critical methyltransferase that catalyzes the transfer of methyl groups to H3K9 39 . We took SUV39H1 as an example to assess the capacity of CEBIT to screen for drugs that modulate various enzymes. The activity of SUV39H1 was evaluated using the assay system shown in Figure 4a . The substrate was H3K9(me0)-PV, and SUV39H1 activity was assessed by enrichment of mCherry signal in the droplets. Indeed, the mCherry signal was enhanced as the concentration of SUV39H1 increased in the in vitro methylation reaction ( Fig. 5a ). Prolonging the reaction time also increased the mCherry signal ( Fig. 5b) . In contrast, methylation of H3K9(me0)-PV by SUV39H1 was largely abolished by a potent SUV39H1 inhibitor, chaetocin, and a feedback inhibitor for generic methyltransferase reactions, S-adenosine homocysteine (SAH). The IC50 values were 1.6 and 56 M for chaetocin and SAH, respectively ( Fig. 5c-d ).
We next explored its potential for the discovery of SUV39H1 inhibitors via HTS. We screened the Selleck-2148 compound library in which chaetocin was added as a positive control. Treatment with chaetocin resulted in the lowest mCherry signal in the phase separated compartments (Fig. 5e , red dot, and 5f). A few compounds from the library also caused low mCherry signals ( Fig. 5e-f ). We selected three of them, Deltarasin, Beta-Lapachone, and NH125 ( Fig. 5e , green) for further testing. Their inhibition of SUV39H1 activity was assessed by detailed dose-response analysis in vitro and their IC50 values were within the single-digit µM range (Fig. 5g ). These results demonstrated that CEBIT worked well for in vitro HTS-based discovery of drugs that modulate SUV39H1
activity, suggesting a general application of CEBIT to other methyltransferase enzymes as well as enzymes for other molecular modifications, such as phosphorylation, acetylation, ubiquitinylation.
Discussion
In this study, we have developed a HTS based drug discovery method called CEBIT which stands for compartmentalization of enhanced biomolecular interactions in test tubes.
It's generally amenable to determining diverse modification-dependent and -independent
BIs and associated enzymes in vitro, and hence discovering therapeutic drugs to modulate these interactions and enzymatic activities via HTS. Our study showed that CEBIT is highly versatile and easy to use, it will become a powerful tool for drugs development.
CEBIT is distinct from existing in vitro PPI detection methods in two respects: 1) it is based on, and hence is analogous to, the general architecture of the prevalent membraneless organelles in cells; and 2) the actual readout is based on the recruitment of nanometer-sized molecules into micron-sized compartments.
Many membraneless organelles assembled via LLPS [13] [14] [15] [16] and the complex compositions of these assemblies are generally divided into two groups: scaffold and client 19 . This architecture revealed two distinct strategies to study various PPIs. In principle, the PPI of interest can serve as either the scaffold or the client. In the former setup, both partners of the PPI are multimerized via fusion to homo-oligomeric proteins and the appearance of phase-separated puncta serves as a readout for the interaction 20, 21, 40 . This strategy is adopted by two recent work, Fluoppi 20 and SPARK 21 . In the latter setup, the recruitment of a client into its binding partner enriched compartments serves as a readout for the interaction, as revealed by our method, CEBIT. The former strategy has some major limitations. Phase separation of multimerized PPI is controlled by several factors, such as valence, concentration, stoichiometry and the binding affinity between PPI of interest. If any of the factors is below the threshold for LLPS, no puncta can be observed. Therefore, it's less efficient and less reliable to use the former strategy for assaying various PPIs. In contrast, it's free for CEBIT to select robust model scaffolds to drive the formation of phase separated compartments, such as SmF fused model PPIs (SH3/PRM, PDZ/PDZ ligand, SUMO3/SIM) and polySUMO/polySIM, these multivalent model interactions provide much more stable platforms to study BIs of interest.
Additionally and importantly, multimerization cannot be easily achieved for many PPI components due to the insolubility of target proteins by fusion to homo-oligomeric protein.
However, we can choose to implement the components of PPI of interest in monovalent fashion by using linear multivalent scaffolds (such as SH34-PRM4 17 and polySUMO-polySIM 19 ) with CEBIT. For at least these reasons, we believe CEBIT is more general, easier, and more reliable than Fluoppi to study various PPIs, just by connecting one partner of the PPI to the scaffold and the other labeled with fluorophore as client.
Fluoppi was claimed to have the potential for drug screening, however, no HTS campaign has been performed to characterize its behavior. Our study has provided solid experimental evidence to demonstrate that CEBIT is very amenable for drug discovery via interactions, however, many factors can interfere with the outcomes of SPR. Our work suggested that CEBIT is very robust for studying diverse interactions and tolerates the factors that interfere SPR. As the readout of CEBIT is the enrichment of fluorophore labeled client in its binding partner containing compartment, its signal dose not affected by the difference in molecular mass between interaction pairs. Compared to FRET, CEBIT exhibited good signal window for study diverse PPIs (PDZ/PDZ ligand, p53/MDM2, Smac/XIAP, H3K9me /chromo domain), what's more, the signal can further be enhanced by increasing the valence of the client (Fig.4b, S6b and S6d). Additionally, CEBIT based assay is simple and efficient, from HTS assay development, to detection and data analysis.
CEBIT is highly versatile and has great scope for adaptation and improvement as far as its applicability and efficiency are concerned. It is conceivable that by fusing
Streptavidin to the phase separation scaffolds, CEBIT can be used to detect any BIs with one component of the interaction pair biotinylated (unpublished data). Besides in vitro studies, this method can also be applied to study diverse PPIs in vivo (see the accompanying manuscript for details) and to identify regulators of these PPIs via HTS in cells. What's more, CEBIT is likely to analyze the interactions between membrane receptors and their ligands by creating membrane-attached receptor-enriched compartments. Other important applications will likely be developed.
Material and methods
Reagents
All modified DNAs and RNAs were provided by Zixi Biotech Company (Beijing, China).
Peptides used in this study were chemically synthesized by GL Biochem Ltd (Shanghai, China).
The fluorescent probe SNAP-Surface Alexa Fluor 546 (#S9132S) was from NEB Biotech. The chemical library Selleck-2148 for HTS and compounds for the dose-response assay were provided by the drug facility of Tsinghua University. Other small molecules were purchased from Selleck.
Plasmid construction
All the plasmids used in this study were constructed following normal molecular cloning In this study, (gSH3)14 and (gPRM)14 were the most extensively used scaffolds. To study protein-protein interactions of interest, one member of the interaction pair was fused to (gSH3)14
as the composite scaffold, and the other was fused with an N-terminal mCherry tag as the client.
To multimerize mCherry-PDZ, a hexamer protein BsHfq was fused at the N terminus.
Another set of scaffold proteins used in this study, polySUMO and polySIM, were modified from the generous gifts from Professor MK Rosen (UTSW, USA). PCR fragments of (SUMO3)5
and SIM6 were inserted into pRSF-Duet1 fused with an N-terminal His6 tag. GFP was further fused to the C-terminus of (SUMO3)5, resulting in g(SUMO3)5. To detect nucleic acid methylation, the indicated DNA or RNA binding domains (MBD for methylated DNA and YTH for methylated RNA) were fused to g(SUMO3)5 to generate the composite scaffold proteins.
A full-length cDNA encoding the methyltransferase SUV39H1 was amplified by PCR and fused with an N-terminal His6-MBP tag in pET-Duet1 (Invitrogen).
Protein expression and purification
Generally, recombinant proteins were expressed in Escherichia coli BL21 (DE3) cells in LB medium with 0.5 mM IPTG at 18℃ for 12-24 hours unless noted. The bacteria were lysed by sonication in buffer (50 mM Tris pH 8.0, 500 mM NaCl, 10% glycerol and 1 mM PMSF), then proteins were purified using nickel-NTA agarose beads (GE Healthcare, UK) followed by ion .
To achieve active enzyme, SUV39H1 and HP1 were co-expressed in Escherichia coli BL21 (DE3) cells and induced with 0.5 mM IPTG at 18℃ for 16 hours. The complex of SUV39H1 and HP1 was affinity-purified with nickel-NTA beads followed by size exclusion chromatography as described above.
Size exclusion chromatography coupled with multiangle light scattering (SEC-MALS)
The analysis was performed as previously described 16 . The protein samples were centrifuged at 12,000g for 10 min to remove any protein precipitation and then loaded into a gel filtration 
Client recruitment and inhibition assays
SmF-derived scaffold proteins, client proteins and inhibitors were mixed together at desired concentrations in buffer KMEI (150 mM KCl, 1 mM EGTA, 1 mM MgCl2, 10 mM imidazole pH7.4) in a total volume of 20 µL and incubated at 4℃ for more than 2 hours to allow the phase-separated droplets gradually sinking down to the bottom of the wells in a 384-well microplate. Images were then taken by high-content microscopy (Opera Phenix, Perkin Elmer, USA) and the fluorescence intensity in the phase-separated droplets was analyzed using the microscopy-linked software Harmony4.8. Images in Figures 1 and 2b were taken and analyzed by confocal microscopy (Nikon A1RSi, Japan).
PolySUMO-and polySIM-based partitioning assay
PolySUMO-and polySIM-based partitioning assays were conducted in buffer containing 20 mM HEPES pH 7.0, 150 mM KCl, 1 mM EGTA, 1 mM MgCl2, 1 mM DTT. The phase-separated scaffolds and recruited clients were mixed thoroughly followed by incubation at 4℃ for more than 2 hours. Images were taken and analyzed by high-content microscopy. 
Partitioning assay of SNAP tagged proteins
Competitive fluorescence polarization (FP) assay
The FP assay was performed as described by Czarna et al 33 All assay components were mixed thoroughly in the buffer (40 mM Tris pH 8.0, 150 mM NaCl, 1 mM EDTA and 5% DMSO) with a total volume of 10 μL. The FP value was measured by using a versatile microplate reader (EVISION, Perkin Elmer, USA) after 30 min incubation at room temperature.
In vitro methylation and detection of H3K9 peptide
The synthetic peptide substrate H3K9(me0)-PV (8 μM) was in vitro-methylated by SUV39H1-HP1 complex in the presence of 20 μM SAM. The reaction was conducted in buffer containing 50 mM Tris pH 8.4, 5 mM MgCl2, 4 mM DTT by incubation at room temperature for 2 hours and ended by heating at 95℃ for 10 min to inactivate the enzyme. Subsequently, 5 μL of the reaction product was analyzed in the CEBIT system consisting of 1 μM (gSH3-CD)14, 1 μM (gPRM)14, 1 μM (mPDZ)6 in a final volume of 20 μL in KMEI. After incubation for 2 hours at 4℃, images were taken by high-content microscopy. mCherry signal in the phase-separated droplets was analyzed. To determine the time-course of enzyme activity, the reaction was stopped by quick-freezing with liquid nitrogen followed by heating at 95℃ for 10 min to inactivate the enzyme. Then the methylation of H3K9(me0)-PV peptide was assessed as indicated.
High-throughput screening
The assay system for screening compounds that disrupt the p53/MDM2 interaction was comprised of 0.5 μM (gSH3-p53)14, 0.5 μM (gPRM)14 and 1 μM mMDM2 in KMEI buffer supplemented with 2% DMSO in a total volume of 20 μL in a 384-well microplate (Greiner Bio-One, Cat. 781090). High-throughput screening was performed using compounds in a commercial library (Selleck-2148). This library contains 2148 small molecules, which was supposed to contain 6 reported MDM2 inhibitors (Nutlin-3, Nutlin-3a, Nutlin-3b, YH239-EE, MI773, and RG7388). However, the solution corresponding to RG7388 in the stock library failed to compete p53/MDM2 after repeated trials while separately purchased RG7388 potently inhibited p53/MDM2 using CEBIT. We concluded that RG7388 in the library used was misplaced and 5 known MDM2 inhibitors (Nutlin-3, Nutlin-3a, Nutlin-3b, YH239-EE, and MI773) actually existed in the library. Each compound was used at a concentration of 20 μM. After thoroughly mixing all the components (scaffolds, client proteins and compounds), the microplates were incubated at 4℃ for overnight before imaging and data collection.
In the screen for inhibitors of the methyltransferase SUV39H1, compounds in the Selleck-2148 library were used at a final concentration of 30 μM. Each compound was added to an in vitro methylation reaction comprising 8 μM H3K9(me0)-PV, 0.4 μM SUV39H1 and 20 μM SAM. The mixture was incubated at room temperature for 2 hours before the reaction was stopped by heating at 60℃ for 30min. Subsequently, 5 μL product from the reaction was assessed using the indicated methylation assay system. After incubation at 4℃ for 2 hours, images were taken by high content microscopy and data were collected. 
